From Adalimumab to orally administered secretory IgA: preclinical characterization of ABC-301
Reformatting therapeutic immunoglobulin G (IgG) antibodies into secretory immunoglobulin A (sIgA) may provide an alternative architecture for mucosal drug delivery. We characterized ABC-301, a recombinant human sIgA1 incorporating the antigen-binding regions of Adalimumab, and evaluated its human tumor necrosis factor alpha (TNFα) neutralization, oral activity in experimental colitis, tissue biodistribution, and susceptibility to patient-derived anti-Adalimumab antibodies. ABC-301 retained human TNFα binding and functional neutralization in vitro. Its whole-molecule molar neutralization IC50 was approximately 3.3-fold lower than that of Adalimumab, a difference of approximately 1.6-fold after normalization to theoretical binding-site number. In dextran sulfate sodium (DSS)-induced colitis, oral ABC-301 attenuated colon shortening and reduced colonic inflammatory myeloid populations and tissue inflammatory biomarkers relative to untreated DSS controls. Following oral administration, iodine-125-associated radioactivity was predominantly detected in gastrointestinal compartments. In seven patient-derived anti-Adalimumab antibody preparations, ABC-301 showed reduced functional susceptibility to inhibition compared with Adalimumab. These findings provide a preclinical proof of concept for IgG-to-sIgA reformatting.
Authors
- Mylène Brousse
- Olivier Favre‐Bulle
- Armelle Cuvillier (ORCID: https://orcid.org/0009-0004-8855-8726)
- Béatrice Lejeune (ORCID: https://orcid.org/0000-0001-9067-6116)
- Amelie Pintat
- Jean-Marc Herbert
Institutions
- United Parcel Service (United States) (US)
- Institut Marcel Mauss (FR)
- Hexcel (United States) (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.64898/2026.11.16.766909
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- preprint
Funders
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique